Breaking News

US Doctors Say The Drug Hydroxychloroquine Malaria Can Treat And Prevent COVID-19

According to a group of American doctors, hydroxychloroquine - a drug to treat malaria and lupus - has helped more than 90% of COVID-19 patients improve their condition.

"We believe there is clear and compelling evidence of benefits both before and after the exposure." 

said two officials from the American Association of Doctors and Surgeons, Dr. Michael Robb and Dr. Jane Orient wrote in a letter to Doug Ducey - Governor of Arizona.

The Epoch Times said the doctors, Robb and Orient, cited April 20 observations from many countries in about 2,333 patients treated with hydroxychloroquine , some in combination with zinc or azithromycin. Among them, 91.6% recorded clinical improvement.

Most of the data in the table ( pdf ) mentions hydroxychloroquine as a treatment for COVID-19, but one study found it to be effective as a preventive measure, doctors said. Most of the data is collected on an observational basis, or not collected through official studies. In some cases, the doctor's name is listed but no details. The data sheet also has some question marks.

Doctors urged Ducey, a Republican, to cancel his executive order banning the prescription of these drugs to stop COVID-19.

“Based on this evidence, we request that you cancel the executive order that prohibits the use of hydroxychloroquine (HCQ) and chloroquine (CQ), and issue an additional order appointing the authorities not to impose any Any requirements for prescribing CQ, HCQ, azithromycin or other drugs for the treatment or prevention of Covid-19, unless this requirement is applied universally to all other approved drugs. be used in addition to the trademark for any other disease." they wrote.
Governor Ducey's executive order ( pdf ) states that:
"Preventive prescriptions for COVID-19 prevention are strictly prohibited unless there is review evidence citing the prophylactic effectiveness of the drug."
Hydroxychloroquine and chloroquine have received emergency use approval from the U.S. Food and Drug Administration for use in COVID-19, although the agency has recently warned about possible side effects. This card is related to the heart.

study published on May 1 showed that patients taking hydroxychloroquine with azithromycin had a larger, longer-lasting QT Syndrome, which could lead to heart palpitations. 

Another study also found an increase in heart rate in patients taking both drugs. Both studies were published in the Journal of the American Medical Association.

No comments